The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Shore Capital downgrades Intertek to 'sell'

Fri, 15th Mar 2024 08:02

(Sharecast News) - Analysts at Shore Capital downgraded Intertek from 'hold' to 'sell' on Friday following the group's recent results.

Shore Capital said the testing and assurance services specialist "likes to test our valuation thoughts", stating it "fundamentally like these activities", being "a necessary and growing element" within the global economy, underpinning quality companies' operations.

However, it stated growth rates were linked closely to GDP exposure and these services were delivered on a business-to-business basis in a competitive market, and noted that the margin ceiling was "surely determined by visible returns on capital".

"Reflecting on valuation metrics, is Intertek a growth or an income stock? FY23A results revealed a change to Intertek's payout ratio from 2.0x to 1.6x from FY24F - the resulting upgrade brings the prospective dividend up to a yield at the current share price of 3.0%. Looking to future growth, however, our forecast model on a cash flow valuation basis suggests fair value at c.£42/share (downside of 15%) - a FY24F PER of 18.0x, reflecting mid-single digit growth metrics," said Shore Cap. "With no substantive change to forecasts, but a c.20% share price outperformance to the market over the past three months, we move to sell."

Reporting by Iain Gilbert at Sharecast.com

Related Shares

More News
15 Apr 2024 09:49

LONDON BROKER RATINGS: UBS raises Crest Nicholson; Stifel cuts CRH

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

26 Mar 2024 09:40

LONDON BROKER RATINGS: Dr Martens cut to 'sell'; BofA likes Tullow

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

25 Mar 2024 10:19

LONDON BROKER RATINGS: SocGen raises Sage; Numis cuts Virgin Money

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of in...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.